04/19/2024 6:27 PM | Apellis Pharmaceuticals (Issuer) Sullivan Timothy Eugene (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/09/2024 3:25 PM | Apellis Pharmaceuticals (Issuer) Deschatelets Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/08/2024 3:17 PM | Apellis Pharmaceuticals (Subject) Deschatelets Pascal (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/01/2024 10:24 AM | Apellis Pharmaceuticals (Subject) Sullivan Timothy Eugene (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024 4:18 PM | Apellis Pharmaceuticals (Issuer) Dunlop A. Sinclair (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2024 11:53 AM | Apellis Pharmaceuticals (Subject) DeLong Mark Jeffrey (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024 2:22 PM | Apellis Pharmaceuticals (Subject) Chopas James George (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
03/13/2024 3:36 PM | Apellis Pharmaceuticals (Subject) Nicholson Nur (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024 6:45 AM | Apellis Pharmaceuticals (Issuer) Watson David O. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 12:37 PM | Apellis Pharmaceuticals (Subject) Sullivan Timothy Eugene (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024 4:10 PM | Apellis Pharmaceuticals (Filer)
| Form 10-K/A | |
02/27/2024 6:35 AM | Apellis Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2024 6:30 AM | Apellis Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/27/2024 6:01 AM | Apellis Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/14/2024 4:18 PM | Apellis Pharmaceuticals (Subject) EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A | |
02/14/2024 8:23 AM | Apellis Pharmaceuticals (Subject) Avoro Capital Advisors LLC (Filed by)
| Form SC 13G/A | |
02/12/2024 2:19 PM | Apellis Pharmaceuticals (Subject) Deschatelets Pascal (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024 2:22 PM | Apellis Pharmaceuticals (Subject) Sullivan Timothy Eugene (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024 2:27 PM | Apellis Pharmaceuticals (Subject) DeLong Mark Jeffrey (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024 2:28 PM | Apellis Pharmaceuticals (Subject) Townsend Adam J. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024 2:43 PM | Apellis Pharmaceuticals (Subject) Watson David O. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024 2:46 PM | Apellis Pharmaceuticals (Subject) Francois Cedric (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2024 3:34 PM | Apellis Pharmaceuticals (Issuer) Sullivan Timothy Eugene (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 3:36 PM | Apellis Pharmaceuticals (Issuer) Townsend Adam J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 3:38 PM | Apellis Pharmaceuticals (Issuer) Watson David O. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 3:23 PM | Apellis Pharmaceuticals (Issuer) Eisele Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 3:26 PM | Apellis Pharmaceuticals (Issuer) Francois Cedric (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 3:28 PM | Apellis Pharmaceuticals (Issuer) Lewis Karen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 3:31 PM | Apellis Pharmaceuticals (Issuer) Nicholson Nur (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2024 9:50 AM | Apellis Pharmaceuticals (Subject) Eisele Jeffrey (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2024 9:04 AM | Apellis Pharmaceuticals (Subject) Lewis Karen (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024 2:15 PM | Apellis Pharmaceuticals (Subject) Deschatelets Pascal (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024 2:15 PM | Apellis Pharmaceuticals (Subject) Townsend Adam J. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024 2:16 PM | Apellis Pharmaceuticals (Subject) DeLong Mark Jeffrey (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024 2:16 PM | Apellis Pharmaceuticals (Subject) Nicholson Nur (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024 2:17 PM | Apellis Pharmaceuticals (Subject) Lewis Karen (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024 2:19 PM | Apellis Pharmaceuticals (Subject) Francois Cedric (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2024 6:28 PM | Apellis Pharmaceuticals (Issuer) Francois Cedric (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/23/2024 5:13 PM | Apellis Pharmaceuticals (Issuer) Sullivan Timothy Eugene (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/23/2024 5:15 PM | Apellis Pharmaceuticals (Issuer) Townsend Adam J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/23/2024 5:17 PM | Apellis Pharmaceuticals (Issuer) Watson David O. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad) “Titan of Tech” Bets Big on Tiny AI Company
He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal…
But our research shows his latest investment could be his most successful venture yet. See how you can invest alongside him |
01/23/2024 5:00 PM | Apellis Pharmaceuticals (Issuer) Chopas James George (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/23/2024 5:01 PM | Apellis Pharmaceuticals (Issuer) DeLong Mark Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/23/2024 5:03 PM | Apellis Pharmaceuticals (Issuer) Deschatelets Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/23/2024 5:05 PM | Apellis Pharmaceuticals (Issuer) Eisele Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/23/2024 5:07 PM | Apellis Pharmaceuticals (Issuer) Lewis Karen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/23/2024 5:11 PM | Apellis Pharmaceuticals (Issuer) Nicholson Nur (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/23/2024 11:36 AM | Apellis Pharmaceuticals (Subject) Eisele Jeffrey (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2024 9:21 AM | Apellis Pharmaceuticals (Subject) Lewis Karen (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024 2:33 PM | Apellis Pharmaceuticals (Subject) Deschatelets Pascal (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024 2:34 PM | Apellis Pharmaceuticals (Subject) Lewis Karen (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024 2:14 PM | Apellis Pharmaceuticals (Subject) Townsend Adam J. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024 2:18 PM | Apellis Pharmaceuticals (Subject) Chopas James George (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024 2:18 PM | Apellis Pharmaceuticals (Subject) Francois Cedric (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024 2:19 PM | Apellis Pharmaceuticals (Subject) Watson David O. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024 2:21 PM | Apellis Pharmaceuticals (Subject) DeLong Mark Jeffrey (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024 2:21 PM | Apellis Pharmaceuticals (Subject) Sullivan Timothy Eugene (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024 2:21 PM | Apellis Pharmaceuticals (Subject) Nicholson Nur (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024 2:23 PM | Apellis Pharmaceuticals (Subject) Eisele Jeffrey (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024 7:00 AM | Apellis Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/18/2024 3:54 PM | Apellis Pharmaceuticals (Issuer) Lewis Karen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/18/2024 3:55 PM | Apellis Pharmaceuticals (Issuer) Eisele Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 3:47 PM | Apellis Pharmaceuticals (Issuer) Deschatelets Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 3:37 PM | Apellis Pharmaceuticals (Issuer) Townsend Adam J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 3:38 PM | Apellis Pharmaceuticals (Issuer) Watson David O. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 3:40 PM | Apellis Pharmaceuticals (Issuer) Nicholson Nur (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 3:41 PM | Apellis Pharmaceuticals (Issuer) DeLong Mark Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 3:43 PM | Apellis Pharmaceuticals (Issuer) Lewis Karen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 3:45 PM | Apellis Pharmaceuticals (Issuer) Chopas James George (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 3:32 PM | Apellis Pharmaceuticals (Issuer) Francois Cedric (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 3:33 PM | Apellis Pharmaceuticals (Issuer) Baumal Caroline (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 3:36 PM | Apellis Pharmaceuticals (Issuer) Sullivan Timothy Eugene (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 11:24 AM | Apellis Pharmaceuticals (Issuer) Eisele Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 9:46 AM | Apellis Pharmaceuticals (Subject) Eisele Jeffrey (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2024 9:18 AM | Apellis Pharmaceuticals (Subject) Lewis Karen (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024 2:48 PM | Apellis Pharmaceuticals (Subject) Eisele Jeffrey (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024 2:49 PM | Apellis Pharmaceuticals (Subject) Francois Cedric (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024 2:50 PM | Apellis Pharmaceuticals (Subject) Chopas James George (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024 2:51 PM | Apellis Pharmaceuticals (Subject) Lewis Karen (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024 2:53 PM | Apellis Pharmaceuticals (Subject) Deschatelets Pascal (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024 2:41 PM | Apellis Pharmaceuticals (Subject) Sullivan Timothy Eugene (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024 2:44 PM | Apellis Pharmaceuticals (Subject) Watson David O. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024 2:44 PM | Apellis Pharmaceuticals (Subject) DeLong Mark Jeffrey (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024 2:47 PM | Apellis Pharmaceuticals (Subject) Nicholson Nur (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024 8:07 AM | Apellis Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/05/2024 3:14 PM | Apellis Pharmaceuticals (Issuer) Baumal Caroline (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 2:16 PM | Apellis Pharmaceuticals (Subject) Baumal Caroline (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024 3:09 PM | Apellis Pharmaceuticals (Issuer) Dunlop A. Sinclair (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 3:10 PM | Apellis Pharmaceuticals (Issuer) Chan Gerald (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 3:12 PM | Apellis Pharmaceuticals (Issuer) O'Brien Stephanie Monaghan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 3:13 PM | Apellis Pharmaceuticals (Issuer) FONTEYNE PAUL R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
READ THIS – If You Missed Out On The AI Boom (Ad) Adam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy.
Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.” Click on Adam's shiny forehead for more details. |
12/28/2023 3:13 PM | Apellis Pharmaceuticals (Issuer) Eisele Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/27/2023 10:04 AM | Apellis Pharmaceuticals (Subject) Eisele Jeffrey (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2023 2:24 PM | Apellis Pharmaceuticals (Subject) Eisele Jeffrey (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2023 3:18 PM | Apellis Pharmaceuticals (Issuer) Watson David O. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/19/2023 11:43 AM | Apellis Pharmaceuticals (Subject) Watson David O. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023 6:04 AM | Apellis Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/05/2023 6:40 PM | Apellis Pharmaceuticals (Issuer) SCHEIBLER LUKAS (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 6:29 PM | Apellis Pharmaceuticals (Issuer) Townsend Adam J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 3:21 PM | Apellis Pharmaceuticals (Issuer) Dunlop A. Sinclair (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |